BLUEPRINT MEDICINES CORP (BPMC)       47.78  +0.03 (+0.06%)

47.78  +0.03 (+0.06%)

US09627Y1091 - Common Stock - After market: 47.78 0 (0%)

EPS Estimates (USD)

Recent Earnings VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 -2.23 -2.54 0.3112.08% Q2 2022 -2.68 -2.27 -0.41-17.97% Q1 2022 -1.79 -1.90 0.115.83% Q4 2021 -5.40 -1.68 -3.72-221.69% Q3 2021 -1.94 -1.66 -0.28-16.74% Q2 2021 -1.86 -1.90 0.041.91% Q1 2021 -1.72 -1.91 0.199.77% Q4 2020 -1.53 -1.66 0.137.64%
Future EPS Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 -9.53 -10.92 12.72%Q4 2022 -2.70 -5.40 50.02%FY 2023 -9.80 -9.53 -2.77%Q1 2023 -2.67 -1.79 -49.24%Q2 2023 -2.67 -2.68 0.44%Q3 2023 -2.38 -2.23 -6.71%Q4 2023 -2.20 -2.70 18.58%FY 2024 -7.35 -9.80 24.99%FY 2025 -4.67 -7.35 36.39%FY 2026 -0.30 -4.67 93.53%FY 2027 0.39 -0.30 229.36%FY 2028 1.69 0.39 332.43%FY 2029 4.40 1.69 160.43%FY 2030 7.33 4.40 66.56%

Revenue Estimates (USD)

Recent Revenue VS Estimates
Period Reported Estimate Difference Surprise Q3 2022 65.977M 44.287M 21.69M48.98% Q2 2022 36.547M 37.988M -1.441M-3.79% Q1 2022 62.731M 39.443M 23.288M59.04% Q4 2021 107.021M 104.74M 2.281M2.18% Q3 2021 24.188M 43.32M -19.132M-44.16% Q2 2021 27.295M 19.542M 7.753M39.67% Q1 2021 21.6M 17.591M 4.009M22.79% Q4 2020 34.1M 29.825M 4.275M14.33%
Future Revenue Estimates
Period Estimate Prior Growth (Y2Y) FY 2022 203.66M 180.08M 13.09%Q4 2022 35.174M 107.021M -67.13%FY 2023 230.54M 203.66M 13.20%Q1 2023 40.327M 62.731M -35.71%Q2 2023 44.353M 36.547M 21.36%Q3 2023 59.903M 65.977M -9.21%Q4 2023 74.397M 35.174M 111.51%FY 2024 396.75M 230.54M 72.10%FY 2025 596.37M 396.75M 50.31%FY 2026 861.74M 596.37M 44.50%FY 2027 1.018B 861.74M 18.13%FY 2028 1.199B 1.018B 17.78%FY 2029 1.449B 1.199B 20.85%FY 2030 1.735B 1.449B 19.74%